D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation, and malignancy

Journal of Pathology

Volumn 187, Issue 5, 1999, Pages 573-581

  Bartkova, Jirina ^a   Rajpert De Meyts, Ewa ^b   Skakkebæk, Niels E ^b   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cell cycle; D type cyclins; Differentiation; Germ cell tumours; Human testis

Indexed keywords

CYCLIN D;

ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CELL PROLIFERATION; CELL TYPE; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TESTIS CANCER; TUMOR DIFFERENTIATION;

ADULT; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN D1; CYCLINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; TESTICULAR NEOPLASMS; TESTIS; TUMOR CELLS, CULTURED;

EID: 0032997009     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO;2-H     Document Type: Article

References (30)

1. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996; 8: 805-814.
2. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-555.
3. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108.
4. Houldsworth J, Reuter V, Bosl GJ, Chaganti RSK. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 1997; 8: 293-299.
5. Sicinski P, Donaher JL, Geng Y, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996; 384: 470-474.
6. Kiess M, Gill RM, Hamel PA. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 1995; 10: 159-166.
7. Meyyappan M, Wong H, Hull C, Riabowol KT. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 1998; 18: 3163-3172.
8. Skakkebæk NE. Possible carcinoma-in-situ of the testis. Lancet 1972; ii: 516-517.
9. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9: 707-718.
10. Bartkova J, Zemanova M, Bartek J. Abundance and subcellular localisation of cyclin D3 in human tumors. Int J Cancer 1996; 65: 323-327.
11. Bartkova J, Zemanova M, Bartek J. Expression of CDK7/CAK in normal and tumour cells of diverse histogenesis, cell-cycle position and differentiation. Int J Cancer 1996; 66: 732-737.
12. Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994; 172: 237-245.
13. Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 1984; 103: 285-293.
14. Pleasure SJ, Lee VM-Y. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993; 35: 585-602.
15. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565-574.
16. Xiong Y, Menninger J, Beach D, Ward D. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992; 13: 575-584.
17. Usuda H, Saito T, Emura I, Naito M. Immunohistochemistry of cyclin D3 in pulmonary carcinomas. Virchows Arch 1996; 428: 159-163.
18. Cordon-Cardo C, Richon VM. Expression of the retinoblastoma protein is regulated in normal human tissue. Am J Pathol 1994; 144: 500-510.
19. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995; 375: 503-506.
20. Lukas J, Bartkova J, Rohde M, Straus M, Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 1995; 15: 2600-2611.
21. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 1995; 12: 309-322.
22. Chaganti RSK, Murty VVVS, Bosl GJ. Molecular genetics of male germ cell tumors. In: Vogelzang NJ, Shipley WU, Scardino PT, Coffey DS, eds. Comprehensive Textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins, 1996: 932-940.
23. Mostert MC, Verkerk AJMH, van de Pol M, et al. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene 1998; 16: 2617-2627.
24. Ando K, Ajchenbaum-Cymbalista F, Griffin JD. Regulation of G1/S transition by cyclins D2 and D3 in hematopietic cells. Proc Natl Acad Sci U S A 1993; 90: 9571-9575.
25. Nakayama H, Nishiyama H, Higuchi T, Kaneko Y, Fukumoto M, Fujita J. Change of cyclin D2 mRNA expression during murine testis development detected by fragmented cDNA subtraction method. Dev Growth Differ 1996; 38: 141-151.
26. Jørgensen N, Rajpert-De Meyts E, Græm N, Müller J, Giwercman A, Skakkebæk NE. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 1995; 72: 223-231.
27. Skakkebæk NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10: 19-28.
28. Rajpert-De Meyts E, Jørgensen N, Brøndum-Nielsen K, Müller J, Skakkebæk NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998; 106: 198-206.
29. Skakkebæk NE, Rajpert-De Meyts E, Jørgensen N, et al. Germ cell cancer and disorders of spermatogenesis. An environmental connection? APMIS 1998; 106: 3-12.
30. Savage MO, Lowe DG. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol 1990; 32: 519-533.